NetworkNewsAudio Archive - Page 21 of 41

MondaySep 16, 2019 6:18 pm

NetworkNewsAudio – SRAX Inc. (NASDAQ: SRAX) Interview

SRAX (NASDAQ: SRAX) is a digital marketing and consumer data management technology company. SRAX's technology unlocks data to reveal brands' core consumers and their characteristics across marketing channels. Monetizing its data sets, SRAX is growing multiple recurring revenue streams through its various platforms. Through the BIGtoken platform, SRAX has developed a consumer-managed data marketplace where people can own and earn from their data thereby offering everyone in the Internet ecosystem choice, transparency, and compensation. SRAX's tools deliver a digital competitive advantage for brands in the CPG, automotive, investor relations, luxury, and lifestyle verticals by integrating all aspects of the advertising…

MondaySep 09, 2019 4:00 pm

NetworkNewsAudio – Quest Patent Research Corp. (QPRC) Interview

Quest Patent Research (OTCQB: QPRC) operates as an intellectual-property, asset-management company delivering financial, strategic and legal resources for IP monetization. It partners with inventors, businesses, corporations and law firms to fully realize the value of IP assets through its suite of value-added services. Quest currently owns, controls or manages more than 115 patents across 11 intellectual property portfolios. Quest trades on the OTCQB Venture Market for early stage and developing U.S. and international companies. Companies are current in their reporting and undergo an annual verification and management certification process. For more information, visit the company’s website at www.QPRC.com. NOTE TO…

FridaySep 06, 2019 8:00 am

NetworkNewsAudio – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Making Significant Advances in Drug Delivery

Related Editorial Drugs play an essential role in treating anything from a mild headache to life-threatening disease — and everything in between. While effectiveness of drugs is what most often captures the spotlight, that effectiveness is closely associated with the drug-delivery technology used, and innovation in this space may have a huge impact on how successful a drug can be. Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) (LXRP Profile) has developed one of the most innovative drug-delivery systems seen in years, a system that can be used to deliver a wide range of drugs in a more palatable and effective…

FridaySep 06, 2019 8:00 am

NetworkNewsAudio – Genprex Inc. (NASDAQ: GNPX) Developing Revolutionary Gene Therapies to Fight Cancer

Related Editorial Recent developments in gene therapy hold out hope for the treatment of a wide range of diseases, including fatal lung cancer. Genprex Inc. (NASDAQ: GNPX) (GNPX Profile) is focused on using gene therapy to tackle lung cancer, developing new drugs that can be used alongside existing treatments. Pfizer Inc. (NYSE: PFE) has created a state-of-the-art research center focused on gene therapy treatments, which it uses for illnesses including cancer. Gilead Sciences Inc. (NASDAQ: GILD) is using biotechnology to tackle a range of challenging diseases, including HIV and hepatitis. Sarepta Therapeutics Inc. (NASDAQ: SRPT) is developing 20 different genetic…

WednesdaySep 04, 2019 8:23 am

NetworkNewsAudio – ORHub Inc. (ORHB) Interview

ORHub Inc. (OTC: ORHB) is a growth-stage data analytics company on a mission to optimize the business of surgery through lean process improvement. As a Microsoft Silver Partner, ORHub leverages the Azure cloud to help customers unlock the power of data captured in the operating room by surfacing key business indicators into a curated set of dynamic dashboards. For more information, visit the company’s website at www.orhub.com. NOTE TO INVESTORS: The latest news and updates relating to ORHB are available in the company’s newsroom at http://nnw.fm/ORHB About NetworkNewsAudio NetworkNewsAudio, a service of NetworkNewsWire (NNW), allows you to sit back and…

WednesdayAug 28, 2019 4:15 pm

NetworkNewsAudio – Neutra Corp. (NTRR) Interview

Neutra (OTCQB: NTRR) is an early-stage research and development company committed to bringing modern, healthy-living solutions to a multibillion-dollar market. Cutting-edge technologies within the nutraceuticals, food and drug, and environmental purification sectors are creating a new kind of world culture — one where consumers are demanding access to products that promote health and stave off potential health dangers. One of the nutraceutical submarkets is the new, thriving, hemp-based CBD market, in which the company intends to participate. For more information, visit the company’s website at www.Neutrainc.com. NOTE TO INVESTORS: The latest news and updates relating to NTRR are available in…

MondayAug 26, 2019 8:00 pm

NetworkNewsAudio – Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT) Interview

Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT), headquartered in Xiamen, China, is a producer, developer and operator of augmented-reality, interactive entertainment games and toys, including interactive educational materials, mobile games and toys with mobile-game features. For more information, visit the company’s website at www.BlueHatGroup.net. NOTE TO INVESTORS: The latest news and updates relating to BHAT are available in the company’s newsroom at http://nnw.fm/BHAT About NetworkNewsAudio NetworkNewsAudio, a service of NetworkNewsWire (NNW), allows you to sit back and listen to market updates, interviews and company press releases. NetworkNewsAudio keeps you informed on publicly traded companies we're watching. The audio clips provide…

FridayAug 23, 2019 8:00 am

NetworkNewsAudio – Genprex Inc. (NASDAQ: GNPX) Making Headway in Clinical Program Expansion, Company Growth

Related Editorial Biotech and biopharma industry leaders are posting record financials and hitting milestone markers in their research and growth, good indicators of a strong market with potential for robust returns on investment. Genprex Inc. (NASDAQ: GNPX) (GNPX Profile) has completed key steps in its overall strategy to expand its clinical development programs and bring Oncoprex(TM) immunogene therapy, its lead drug candidate, to commercialization. Over the past five years, Amgen Inc. (NASDAQ: AMGN) has invested nearly $19 billion in R&D and, as a result, is now advancing a record number of clinical assets. Biogen Inc. (NASDAQ: BIIB) has added four new programs to…

ThursdayAug 15, 2019 8:00 am

NetworkNewsAudio – Grapefruit Boulevard Investments Inc. (IGNG) Interview

Grapefruit Boulevard Investments, a wholly owned subsidiary of Imaging3 (OTCQB: IGNG), holds California permits and licenses to both manufacture and distribute cannabis products. Grapefruit’s cannabis and CBD extraction laboratory and distribution facilities are located in the industry recognized Coachillin’ Industrial Cultivation and Ancillary Canna-Business Park in Desert Hot Springs, located on the extension of North Canyon Rd., approximately 10 miles north of downtown Palm Springs. Grapefruit obtained its California cannabis licenses in January of 2018 and commenced distribution of cannabis products thereafter. Grapefruit’s vision is to become a seed to sale, fully vertically integrated ethical and compliant cannabis and CBD…

MondayAug 05, 2019 7:00 pm

NetworkNewsAudio – Siyata Mobile Inc. (TSX.V: SIM) (OTCQX: SYATF) Interview

A TSX Venture Top 50 Company, Siyata Mobile Inc. (TSX.V: SIM) (OTCQX: SYATF) is a leading global developer and provider of cellular communications systems for enterprise customers, specializing in connected vehicle products for professional fleets, marketed under the Uniden® Cellular brand. Since developing the world’s first 3G connected vehicle device, Siyata has been a pioneer in the industry, launching the world’s first 4G LTE all-in-one fleet communications device in 2017. Incorporating voice, push-to-talk over cellular, data, and fleet management solutions into a single device, the company aims to become the connected vehicle communications device of choice for commercial vehicles and…